SCHEMBL25856485

SCHEMBL25856485

CC1CCN(C2CCN(C(=O)CN)CC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
NPC1 O15118 3/20 0.53
KDM4E B2RXH2 4/20 0.50
POLB P06746 1/20 0.50
CHRM1 P11229 1/20 0.44
CPN1 P15169 1/20 0.43
CPB2 Q96IY4 1/20 0.43
HPGD P15428 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALOX15 P16050 1/20 0.40
PHGDH O43175 1/20 0.39
MGLL Q99685 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP2D6 P10635 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8284598 0.89 ALDH1A1 (0.64) ALDH1A1NPC1KDM4EPOLBCPN1
Hydrochloric Acid SCHEMBL1692191 0.87 ALDH1A1 (0.62) ALDH1A1NPC1KDM4EPOLBCPN1
SCHEMBL21561085 0.84 KDM4E (0.55) ALDH1A1NPC1KDM4EPOLBCHRM1
SCHEMBL19203542 0.83 ACHE (0.50) ALDH1A1KDM4ECHRM1CPN1CPB2
SCHEMBL4714675 0.82 MEN1 (0.56) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL4678853 0.79 L3MBTL3 (0.50) ALDH1A1KDM4ECPN1CPB2CYP2C9
SCHEMBL19196834 0.79 MEN1 (0.40) ALDH1A1KDM4ECHRM1CPN1CPB2
SCHEMBL13772828 0.79 KDM4E (0.50) ALDH1A1NPC1KDM4EPOLBMEN1
SCHEMBL14290100 0.78 ALDH1A1 (0.53) ALDH1A1NPC1POLBCPN1CPB2
SCHEMBL15450906 0.78 KDM4E (0.51) ALDH1A1NPC1KDM4EPOLBCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed